Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: economics

“According to WAM, stem cells are extracted from the patient’s blood and then reintroduced in an “activated” state to the lungs through inhalation after being nebulized into a fine mist.

ADSCC researchers said the mist had a therapeutic effect, helping to regenerate lung cells and alter the response of the immune system to stop it from overreacting to the COVID-19 infection and causing more damage to healthy cells.

The treatment has undergone and successfully passed the first stage of clinical trials with further tests to demonstrate its effectiveness being carried out over the next two weeks.”

LONDON: An aerosol treatment for the coronavirus disease (COVID-19) developed by a team of doctors and researchers in the UAE had shown “promising” results, the Emirates News Agency (WAM) reported on Friday.

The treatment was given to 73 patients suffering with COVID-19 in the UAE and all of them went on to make a complete recovery.

The Emirati Ministry of Economy said on Friday it had granted a patent to the Abu Dhabi Stem Cell Center (ADSCC) to develop the treatment further through the use of stem cells.

Read more | >

What are some of ways that technology can be used to combat things like racism, bipartisan politics, Islamophobia, antisemitism, and extreme prejudice? Especially when these things are systemically embedded in certain cultures to the point that rationality seems to fly out the window? I see conversations on social media in peaceful international groups such as this one as a great potential stepping stone to mediate the tension between groups who seem to be devoted to blind hatred for one another. What are some other ways technology can advance social and political sciences?

“This article analyzes the narratives of Islamophobia in Hindu Nationalism (Hindutva). Specifically, it analyzes how Indian Prime Minister Narendra Modi, from the Hindu nationalist Bharatiya Janata Party (BJP), articulates Islamophobia in his speeches, interviews, and podcasts. In total, a discourse analysis of 35 such documents has been conducted. Conceptually, this article applies the notion of language-games to understand how Modi articulates Islamophobia. The article contends that while Modi’s Islamophobia is executed subtly, it is nonetheless a function of the way in which Hindutva conceives of Muslims as subordinate to Hindus. Two Islamophobic narratives in Modi’s political discourse have been mapped out: the erasure of Indian Muslim histories in Modi’s economic development agenda, and the characterization of Hinduism as having a taming effect on Islam in India. The article provides a conceptual overview of language-games and a review of how Hindutva defines Hindus and Muslims, before analyzing how Modi articulates Islamophobia. The article concludes by suggesting that a Hindutva-driven Islamophobia may have permeated into the Hindu mainstream.”

Read more | >

Investment in the fast-growing space industry was booming well into the first quarter of 2020 but private capital has largely frozen as the coronavirus pandemic strikes the U.S., leading both civil and military agencies to step up funding for corporate partners.

“We kicked into high gear as soon as it was apparent a lot of companies were not going to be able to conduct business as usual due to distancing requirements,” Mike Read, International Space Station business and economic development manager at NASA’s Johnson Space Center, told CNBC.

U.S. equity investment in space companies totaled $5.4 billion across 36 deals in the first quarter, according to a report Friday by NYC-based firm Space Capital. But the second quarter is likely to just see a fraction of that investment, according to Space Capital managing partner Chad Anderson, as deal flow in the U.S. will follow China’s path. Chinese investment in space was climbing by record amounts until the first quarter, when “activity in China was basically shut off,” Anderson said.

Read more | >

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Stanley Plotkin, Professor Emeritus at both Wistar Institute and the University of Pennsylvania and consultant to the vaccine industry.

Ira Pastor Comments:

So as we sit here a few months into the global covid-19 pandemic, one big question on everyone’s mind is when will we see the first mass produced vaccine against this current strain, especially as it looks like in the United States there will be some loosening of quarantine / “shelter in place” rules in the to re-start the economy.

Dr. Stanley Plotkin is an American physician, scientist, and scholar, in many circles referred to as the Godfather of Vaccines”, who in the 1960s, while working at Wistar Institute in Philadelphia, played a pivotal role in discovery of a vaccine against Rubella virus (also known as German measles or three-day measles), which is now used worldwide (as a key component of the MMR vaccine — a combination vaccine also that protects against measles and mumps) and has worked extensively on the development and application of a wide range of other vaccines including polio, rabies, varicella, rotavirus and cytomegalovirus.

Dr. Plotkin graduated from New York University in 1952 and obtained a medical degree at Downstate Medical Center in Brooklyn. He was a resident in pediatrics at the Children’s Hospital of Philadelphia and at the Hospital for Sick Children in London.

Read more | >

We’re getting many calls and emails from WGN viewers who say they spotted a strange string of lights crossing the night sky on Sunday.

No, it’s not planes flying in formation or a meteor shower. It’s actually a satellite string that’s part of SpaceX’s “Starlink” project. You can read more about it below.

While much of the world economy stands still, SpaceX is running full speed ahead.

Read more | >

Even giant economic powerhouses have not been spared, with California—one of the wealthiest states in the United States thanks to its booming tech sector—having obliterated all its job growth over the last decade in just two months.

But now a renewable energy think-tank says directing those stimulus dollars to renewable energy investments could not only help tackle global climate emergency but spur massive economic gains post-Covid-19 for decades to come.

The International Renewable Energy Agency (IRENA) —an organization dedicated to promoting global adoption of renewable energy and facilitating sustainable use—says that it will cost the global economy $95 trillion to help return things to normal.

Read more | >

Download the full report here.

In 2017, Bellingcat and Transparency International UK published their joint report, “Offshore in the UK”, describing the phenomenon of Scottish Limited Partnerships (“SLPs”) and their use as a mechanism in global money laundering scandals and a range of illicit activities. Since then, SLPs have continued to be implicated in further scandals, perhaps most notably the Azerbaijani Laundromat, a scheme where $2.9 billion was laundered through UK companies.

In the same year, SLPs became obliged to register their Person of Significant Control at Companies House, and the boom in registrations ended. The government subsequently ran a public consultation into limited partnerships, and published its conclusions in December 2018. Currently, SLP registrations are at their lowest level since 2010. Nevertheless, a lack of regulation allowed thousands of opaquely owned partnerships, typically with no tangible link to the Uk, to flourish over a seven year period. We do not have the details of the business activities of these SLPs, who controlled them, or who their true beneficial owners are.

Read more | >

April 2020

The COVID-19 pandemic caused by SARS-CoV-2 has brought about an unprecedented crisis, taking a heavy toll on human health, lives as well as the global economy. There are no SARS-CoV-2-specific treatments or vaccines available due to the novelty of this virus. Hence, rapid development of effective vaccines against SARS-CoV-2 is urgently needed. Here we developed a pilot-scale production of a purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc), which induced SARS-CoV-2-specific neutralizing antibodies in mice, rats and non-human primates. These antibodies potently neutralized 10 representative SARS-CoV-2 strains, indicative of a possible broader neutralizing ability against SARS-CoV-2 strains circulating worldwide. Immunization with two different doses (3μg or 6 μg per dose) provided partial or complete protection in macaques against SARS-CoV-2 challenge, respectively, without any antibody-dependent enhancement of infection. Systematic evaluation of PiCoVacc via monitoring clinical signs, hematological and biochemical index, and histophathological analysis in macaques suggests that it is safe. These data support the rapid clinical development of SARS-CoV-2 vaccines for humans.

One Sentence Summary A purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc) confers complete protection in non-human primates against SARS-CoV-2 strains circulating worldwide by eliciting potent humoral responses devoid of immunopathology.

The authors have declared no competing interest.

Read more | >

Dozens of teams of researchers across the world are racing to develop a vaccine to stem the spread of coronavirus infections, bring down death rates, and allow countries to reopen their economies.

However, Severin Schwan, Roche’s chief executive, said he was skeptical that a vaccine could be fully tested, manufactured, and widely distributed within the next 12 to 18 months.

“I’m afraid that the most likely scenario is that we will not have a vaccine before the end of next year,” Schwan said on a Wednesday conference call with reporters, adding that an 18-month timeline is “very ambitious.”

Read more | >